United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alk-abello ltd - dermatophagoides farinae allergen extract; dermatophagoides pteronyssinus allergen extract - oral lyophilisate

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - european house dust mite extract, quantity: 6 sq-hdm; american house dust mite extract, quantity: 6 sq-hdm - tablet - excipient ingredients: gelatin; sodium hydroxide; purified water; mannitol - allergic rhinitis acarizax is indicated for the treatment of house dust mite (hdm) allergic rhinitis not well controlled despite use of symptom relieving medication in adults and adolescents (? 12 years). allergic asthma acarizax is indicated for the treatment of hdm allergic asthma not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis in adults. patients? asthma status should be carefully evaluated before the initiation of treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - european house dust mite, quantity: 150 ir; american house dust mite, quantity: 150 ir - tablet - excipient ingredients: magnesium stearate; croscarmellose sodium; lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; mannitol - treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - european house dust mite, quantity: 150 ir; american house dust mite, quantity: 150 ir - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; mannitol - treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - dermatophagoides farinae allergen extract 50 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 50 ir ((european house dust mite)); dermatophagoides farinae allergen extract 150 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 150 ir ((dermatophagoides pteronyssinus)) - sublingual tablet - 100ir & 300ir - active: dermatophagoides farinae allergen extract 50 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 50 ir ((european house dust mite)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose active: dermatophagoides farinae allergen extract 150 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 150 ir ((dermatophagoides pteronyssinus)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - actair is indicated for the treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - dermatophagoides farinae allergen extract 150 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 150 ir ((european house dust mite)) - sublingual tablet - 300 ir - active: dermatophagoides farinae allergen extract 150 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 150 ir ((european house dust mite)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - actair is indicated for the treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - dermatophagoides farinae allergen extract 6 sq-hdm; dermatophagoides pteronyssinus allergen extract 6 sq-hdm - sublingual tablet - 12 sq-hdm - active: dermatophagoides farinae allergen extract 6 sq-hdm dermatophagoides pteronyssinus allergen extract 6 sq-hdm excipient: gelatin mannitol sodium hydroxide - acarizax is indicated for the treatment of adults diagnosed with: - house dust mite (hdm) allergic rhinitis (ar) not well controlled despite use of symptom relieving medication or - hdm allergic asthma (aa) not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis. patients' asthma status should be carefully evaluated before the initiation of treatment.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbott laboratories (m) sdn. bhd. - der far extract (dermatophagoides farinae); der pte extract (dermatophagoides pteronyssinus) -